Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-16

Clinical Trial Update: Natrunix or Placebo in Combination With Methotrexate in Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating Natrunix vs placebo in combination with methotrexate for rheumatoid arthritis; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOTREXATE (METHOTREXATE)
  • Natrunix

Snippet

Sponsor: XBiotech, Inc. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED